Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in joints such as knee joint.
The recent developments in the chondroplasty treatment includes development of radio frequency chondroplasty which uses radio frequency waves to fill cracks and wedges in the cartilage structure and to stimulate growth.
There is also an increasing trend towards miniaturization of devices. Development of alloys have advanced the shavers and made them more efficient to ensure less trauma to the tissue being treated.
Free Sample Copy Download at https://www.marketresearchfuture.com/sample_request/4205
Competitive Analysis:
Key players profiled in the report are –
- Braun Melsungen AG
- NuOrtho Surgical Inc.
- Zimmer Biomet Holdings Inc.
- Smith & Nephew plc
- Nebula Inc.
- Gpcmedical
- Osiris Therapeutics Inc.
- Sklar Surgical Instruments
- Stryker Corporation and others.
Intended Audience
- Global Chondroplasty treatment manufacturers & suppliers
- Research and development (R&D) companies
- Hospitals and clinics
- Academic institutes and universities
Regional Analysis:
The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Chondroplasty Industry. The good reimbursement scenario and the greater awareness in the developed regions drive the market.
Europe is the second largest market in the world due to high income and healthcare penetration.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.
Comments
Post a Comment